首页 | 本学科首页   官方微博 | 高级检索  
检索        

舒血宁注射液治疗急性脑梗死100例疗效观察
引用本文:周莎白,程晓秧,陈顺泉.舒血宁注射液治疗急性脑梗死100例疗效观察[J].中国实用神经疾病杂志,2005,8(2):6-7.
作者姓名:周莎白  程晓秧  陈顺泉
作者单位:杭州市红十字会医院神经内科,杭州,310003;杭州市红十字会医院神经内科,杭州,310003;杭州市红十字会医院神经内科,杭州,310003
摘    要:目的 观察银杏叶提取物舒血宁注射液对急性脑梗死的疗效和安全性。方法 将 2 0 0例急性脑梗死患者随机分为治疗组和对照组 ,治疗组 10 0例给予舒血宁注射液 2 0ml加入NS 5 0 0ml静滴 ,qd ,15d ;对照组 10 0例给予复方丹参注射液 3 0ml加入NS5 0 0ml静滴 ,qd ,15d ,其余常规治疗相同。结果 治疗组神经功能缺损评分减少明显优于对照组 (P <0 0 1) ,其血液流变学指标较对照组有显著性差异 (P <0 0 5 )。结论 舒血宁治疗急性脑梗死安全有效。

关 键 词:舒血宁  急性脑梗死  疗效观察
文章编号:1672-9218(2005)02-0006-02
修稿时间:2004年12月20

Clinical study of shuxuening injection in the treatment of acute cerebral infarction
Zhou Shabai,Cheng Xiaoyang,Chen Shunquan.Clinical study of shuxuening injection in the treatment of acute cerebral infarction[J].Chinese Journal of Practical Neruous Diseases,2005,8(2):6-7.
Authors:Zhou Shabai  Cheng Xiaoyang  Chen Shunquan
Institution:Zhou Shabai,Cheng Xiaoyang,Chen Shunquan,Department of Neurology,red cross hospital of Hangzhou,Hangzhou 310003
Abstract:Objective To study the efficacy and safety of shuxuening in the treatment of acute cerebral infarction.Methods Two hundreds patients with ACI were randomly divided into treatment group and control group respectively.The patients in each group were treated with routine therapy ,shuxuening was added to the treatment group,composita salvia miltiorrhizae infection was administered in the control group .The time of two groups treatment was fifteen days.Results The neurofunction deficit score (NFD) in the treatment group was better than in the control group(P<0.01). The changes of hemorheology parameters were significiant differences in the treatment group comparing with the control group(P<0.05).Conclusion Shuxuening is effective and safe in the treatment of acute cerebral infarction.
Keywords:Shuxuening  Acute cerebral infarction  Observation of efficacy
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号